PreveCeutical Medical Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was CAD 1.48 million compared to CAD 1.73 million a year ago. Basic loss per share from continuing operations was CAD 0.003 compared to CAD 0.003 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | 0.00% | +25.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.78M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PREV Stock
- News PreveCeutical Medical Inc.
- PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022